• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency

cafead

Administrator
Staff member
  • cafead   Mar 06, 2023 at 11:52: PM
via The hormonal shot Makena is the only treatment available to lower the risk of early labor. But the FDA has sought its withdrawal since a 2019 study showed it didn’t work.

article source